molecular function |
| GO:0070742 | | C2H2 zinc finger domain binding | | Interacting selectively and non-covalently with a C2H2-type zinc finger domain of a protein. The C2H2 zinc finger is the classical zinc finger domain, in which two conserved cysteines and histidines co-ordinate a zinc ion. |
| GO:0003677 | | DNA binding | | Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid). |
| GO:0008301 | | DNA binding, bending | | The activity of binding selectively and non-covalently to and distorting the original structure of DNA, typically a straight helix, into a bend, or increasing the bend if the original structure was intrinsically bent due to its sequence. |
| GO:0000978 | | RNA polymerase II core promoter proximal region sequence-specific DNA binding | | Interacting selectively and non-covalently with a sequence of DNA that is in cis with and relatively close to a core promoter for RNA polymerase II. |
| GO:0000977 | | RNA polymerase II regulatory region sequence-specific DNA binding | | Interacting selectively and non-covalently with a specific sequence of DNA that is part of a regulatory region that controls the transcription of a gene or cistron by RNA polymerase II. |
| GO:0070016 | | armadillo repeat domain binding | | Interacting selectively and non-covalently with the armadillo repeat domain of a protein, an approximately 40 amino acid long tandemly repeated sequence motif first identified in the Drosophila segment polarity protein armadillo. Arm-repeat proteins are involved in various processes, including intracellular signalling and cytoskeletal regulation. |
| GO:0008013 | | beta-catenin binding | | Interacting selectively and non-covalently with the beta subunit of the catenin complex. |
| GO:0003682 | | chromatin binding | | Interacting selectively and non-covalently with chromatin, the network of fibers of DNA, protein, and sometimes RNA, that make up the chromosomes of the eukaryotic nucleus during interphase. |
| GO:0043027 | | cysteine-type endopeptidase inhibitor activity involved in apoptotic process | | Stops, prevents or reduces the activity of a cysteine-type endopeptidase involved in the apoptotic process. |
| GO:0035326 | | enhancer binding | | Interacting selectively and non-covalently with an enhancer, a transcription regulatory region that is somewhat distal from the core promoter and which enhances transcription from that promoter. |
| GO:0030284 | | estrogen receptor activity | | Combining with estrogen and transmitting the signal within the cell to trigger a change in cell activity or function. |
| GO:0030331 | | estrogen receptor binding | | Interacting selectively and non-covalently with an estrogen receptor. |
| GO:0045295 | | gamma-catenin binding | | Interacting selectively and non-covalently with the gamma subunit of the catenin complex. |
| GO:0042393 | | histone binding | | Interacting selectively and non-covalently with a histone, any of a group of water-soluble proteins found in association with the DNA of eukaroytic chromosomes. They are involved in the condensation and coiling of chromosomes during cell division and have also been implicated in nonspecific suppression of gene activity. |
| GO:0042826 | | histone deacetylase binding | | Interacting selectively and non-covalently with the enzyme histone deacetylase. |
| GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| GO:0043565 | | sequence-specific DNA binding | | Interacting selectively and non-covalently with DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA e.g. promotor binding or rDNA binding. |
| GO:0003705 | | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding | | Interacting selectively and non-covalently with a sequence of DNA that is in a distal enhancer region for RNA polymerase II (RNAP II) in order to modulate transcription by RNAP II. |
| GO:0003700 | | transcription factor activity, sequence-specific DNA binding | | Interacting selectively and non-covalently with a specific DNA sequence in order to modulate transcription. The transcription factor may or may not also interact selectively with a protein or macromolecular complex. |
| GO:0008134 | | transcription factor binding | | Interacting selectively and non-covalently with a transcription factor, any protein required to initiate or regulate transcription. |
| GO:0044212 | | transcription regulatory region DNA binding | | Interacting selectively and non-covalently with a DNA region that regulates the transcription of a region of DNA, which may be a gene, cistron, or operon. Binding may occur as a sequence specific interaction or as an interaction observed only once a factor has been recruited to the DNA by other factors. |
| GO:0001077 | | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding | | Interacting selectively and non-covalently with a sequence of DNA that is in cis with and relatively close to a core promoter for RNA polymerase II (RNAP II) in order to activate or increase the frequency, rate or extent of transcription from the RNAP II promoter. |
| GO:0001228 | | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding | | Interacting selectively and non-covalently with a sequence of DNA that is in the transcription regulatory region for RNA polymerase II (RNAP II) in order to activate or increase the frequency, rate or extent of transcription from the RNAP II promoter. |
biological process |
| GO:0042100 | | B cell proliferation | | The expansion of a B cell population by cell division. Follows B cell activation. |
| GO:0030509 | | BMP signaling pathway | | A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription. |
| GO:0033153 | | T cell receptor V(D)J recombination | | The process in which T cell receptor V, D, and J, or V and J gene segments, depending on the specific locus, are recombined within a single locus utilizing the conserved heptamer and nonomer recombination signal sequences (RSS). |
| GO:0045063 | | T-helper 1 cell differentiation | | The process in which a relatively unspecialized T cell acquires the specialized features of a T-helper 1 (Th1) cell. A Th1 cell is a CD4-positive, alpha-beta T cell that has the phenotype T-bet-positive and produces interferon-gamma. |
| GO:0016055 | | Wnt signaling pathway | | The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell and ending with a change in cell state. |
| GO:0046632 | | alpha-beta T cell differentiation | | The process in which a precursor cell type acquires the specialized features of an alpha-beta T cell. An alpha-beta T cell is a T cell that expresses an alpha-beta T cell receptor complex. |
| GO:0060033 | | anatomical structure regression | | The developmental process in which an anatomical stucture is destroyed as a part of its normal progression. |
| GO:0031100 | | animal organ regeneration | | The regrowth of a lost or destroyed animal organ. |
| GO:1902262 | | apoptotic process involved in blood vessel morphogenesis | | Any apoptotic process that is involved in blood vessel morphogenesis. |
| GO:0060561 | | apoptotic process involved in morphogenesis | | Any apoptotic process that contributes to the shaping of an anatomical structure. |
| GO:0001569 | | branching involved in blood vessel morphogenesis | | The process of coordinated growth and sprouting of blood vessels giving rise to the organized vascular system. |
| GO:0060070 | | canonical Wnt signaling pathway | | The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes. In this pathway, the activated receptor signals via downstream effectors that result in the inhibition of beta-catenin phosphorylation, thereby preventing degradation of beta-catenin. Stabilized beta-catenin can then accumulate and travel to the nucleus to trigger changes in transcription of target genes. |
| GO:0007155 | | cell adhesion | | The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via cell adhesion molecules. |
| GO:0060326 | | cell chemotaxis | | The directed movement of a motile cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis). |
| GO:0048468 | | cell development | | The process whose specific outcome is the progression of the cell over time, from its formation to the mature structure. Cell development does not include the steps involved in committing a cell to a specific fate. |
| GO:0071345 | | cellular response to cytokine stimulus | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cytokine stimulus. |
| GO:0071353 | | cellular response to interleukin-4 | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-4 stimulus. |
| GO:0060710 | | chorio-allantoic fusion | | The cell-cell adhesion process in which the cells of the chorion fuse to the cells of the allantois. |
| GO:0021542 | | dentate gyrus development | | The process whose specific outcome is the progression of the dentate gyrus over time, from its formation to the mature structure. The dentate gyrus is one of two interlocking gyri of the hippocampus. It contains granule cells, which project to the pyramidal cells and interneurons of the CA3 region of the ammon gyrus. |
| GO:0030326 | | embryonic limb morphogenesis | | The process, occurring in the embryo, by which the anatomical structures of the limb are generated and organized. A limb is an appendage of an animal used for locomotion or grasping. |
| GO:0001837 | | epithelial to mesenchymal transition | | A transition where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell. |
| GO:0048069 | | eye pigmentation | | Establishment of a pattern of pigment in the eye of an organism. |
| GO:0060325 | | face morphogenesis | | The process in which the anatomical structures of the face are generated and organized. The face is the ventral division of the head. |
| GO:0021873 | | forebrain neuroblast division | | The division of a neuroblast located in the forebrain. Neuroblast division gives rise to at least another neuroblast. |
| GO:0021879 | | forebrain neuron differentiation | | The process in which a relatively unspecialized cell acquires specialized features of a neuron that will reside in the forebrain. |
| GO:0021861 | | forebrain radial glial cell differentiation | | The process in which neuroepithelial cells of the neural tube give rise to radial glial cells, specialized bipotential progenitors cells of the forebrain. Differentiation includes the processes involved in commitment of a cell to a specific fate. |
| GO:0021943 | | formation of radial glial scaffolds | | The formation of scaffolds from a radial glial cell. The scaffolds are used as a substrate for the radial migration of cells. |
| GO:0021766 | | hippocampus development | | The progression of the hippocampus over time from its initial formation until its mature state. |
| GO:0043966 | | histone H3 acetylation | | The modification of histone H3 by the addition of an acetyl group. |
| GO:0043967 | | histone H4 acetylation | | The modification of histone H4 by the addition of an acetyl group. |
| GO:0021854 | | hypothalamus development | | The progression of the hypothalamus region of the forebrain, from its initial formation to its mature state. |
| GO:0001822 | | kidney development | | The process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and/or excretes the end products of body metabolism in the form of urine. |
| GO:0030879 | | mammary gland development | | The process whose specific outcome is the progression of the mammary gland over time, from its formation to the mature structure. The mammary gland is a large compound sebaceous gland that in female mammals is modified to secrete milk. Its development starts with the formation of the mammary line and ends as the mature gland cycles between nursing and weaning stages. |
| GO:0048747 | | muscle fiber development | | The process whose specific outcome is the progression of the muscle fiber over time, from its formation to the mature structure. In skeletal muscle, fibers are formed by the maturation of myotubes. They can be classed as slow, intermediate/fast or fast. |
| GO:0043392 | | negative regulation of DNA binding | | Any process that stops or reduces the frequency, rate or extent of DNA binding. DNA binding is any process in which a gene product interacts selectively with DNA (deoxyribonucleic acid). |
| GO:0043066 | | negative regulation of apoptotic process | | Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process. |
| GO:0071866 | | negative regulation of apoptotic process in bone marrow | | Any process that stops, prevents, or reduces the frequency, rate or extent of the occurrence or rate of cell death by apoptotic process in the bone marrow. |
| GO:0090090 | | negative regulation of canonical Wnt signaling pathway | | Any process that decreases the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes. |
| GO:0022408 | | negative regulation of cell-cell adhesion | | Any process that stops, prevents or reduces the rate or extent of cell adhesion to another cell. |
| GO:0043154 | | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process | | Any process that stops, prevents, or reduces the frequency, rate or extent of a cysteine-type endopeptidase activity involved in the apoptotic process. |
| GO:0071899 | | negative regulation of estrogen receptor binding | | Any process that stops, prevents, or reduces the frequency, rate or extent of estrogen receptor binding, interacting selectively with an estrogen receptor. |
| GO:0032696 | | negative regulation of interleukin-13 production | | Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-13 production. |
| GO:0032713 | | negative regulation of interleukin-4 production | | Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-4 production. |
| GO:0032714 | | negative regulation of interleukin-5 production | | Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-5 production. |
| GO:0045843 | | negative regulation of striated muscle tissue development | | Any process that stops, prevents, or reduces the frequency, rate or extent of striated muscle development. |
| GO:0000122 | | negative regulation of transcription from RNA polymerase II promoter | | Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
| GO:0045892 | | negative regulation of transcription, DNA-templated | | Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription. |
| GO:0001755 | | neural crest cell migration | | The characteristic movement of cells from the dorsal ridge of the neural tube to a variety of locations in a vertebrate embryo. |
| GO:0030223 | | neutrophil differentiation | | The process in which a myeloid precursor cell acquires the specialized features of a neutrophil. |
| GO:0071895 | | odontoblast differentiation | | The process in which a relatively unspecialized cell of neural crest origin acquires the specialized features of an odontoblast, a cell on the outer surface of the dental pulp whose biological function is the creation of dentin. |
| GO:0042475 | | odontogenesis of dentin-containing tooth | | The process whose specific outcome is the progression of a dentin-containing tooth over time, from its formation to the mature structure. A dentin-containing tooth is a hard, bony organ borne on the jaw or other bone of a vertebrate, and is composed mainly of dentin, a dense calcified substance, covered by a layer of enamel. |
| GO:0001649 | | osteoblast differentiation | | The process whereby a relatively unspecialized cell acquires the specialized features of an osteoblast, a mesodermal or neural crest cell that gives rise to bone. |
| GO:0060021 | | palate development | | The biological process whose specific outcome is the progression of the palate from an initial condition to its mature state. This process begins with the formation of the structure and ends with the mature structure. The palate is the partition that separates the nasal and oral cavities. |
| GO:0048341 | | paraxial mesoderm formation | | The process that gives rise to the paraxial mesoderm. This process pertains to the initial formation of the structure from unspecified parts. |
| GO:0043923 | | positive regulation by host of viral transcription | | Any process in which a host organism activates or increases the frequency, rate or extent of viral transcription, the synthesis of either RNA on a template of DNA or DNA on a template of RNA. |
| GO:0090068 | | positive regulation of cell cycle process | | Any process that increases the rate, frequency or extent of a cellular process that is involved in the progression of biochemical and morphological phases and events that occur in a cell during successive cell replication or nuclear replication events. |
| GO:0030307 | | positive regulation of cell growth | | Any process that activates or increases the frequency, rate, extent or direction of cell growth. |
| GO:0030335 | | positive regulation of cell migration | | Any process that activates or increases the frequency, rate or extent of cell migration. |
| GO:0008284 | | positive regulation of cell proliferation | | Any process that activates or increases the rate or extent of cell proliferation. |
| GO:0071864 | | positive regulation of cell proliferation in bone marrow | | A process that activates or increases the frequency, rate or extent of cell proliferation in the bone marrow. |
| GO:0022409 | | positive regulation of cell-cell adhesion | | Any process that activates or increases the rate or extent of cell adhesion to another cell. |
| GO:0010718 | | positive regulation of epithelial to mesenchymal transition | | Any process that increases the rate, frequency, or extent of epithelial to mesenchymal transition. Epithelial to mesenchymal transition is where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell. |
| GO:0010628 | | positive regulation of gene expression | | Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form. |
| GO:0030854 | | positive regulation of granulocyte differentiation | | Any process that activates or increases the frequency, rate or extent of granulocyte differentiation. |
| GO:0045944 | | positive regulation of transcription from RNA polymerase II promoter | | Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
| GO:0045893 | | positive regulation of transcription, DNA-templated | | Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription. |
| GO:0030111 | | regulation of Wnt signaling pathway | | Any process that modulates the frequency, rate or extent of the activity of the Wnt signal transduction pathway. |
| GO:0022407 | | regulation of cell-cell adhesion | | Any process that modulates the frequency, rate or extent of attachment of a cell to another cell. |
| GO:0006357 | | regulation of transcription from RNA polymerase II promoter | | Any process that modulates the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
| GO:0006355 | | regulation of transcription, DNA-templated | | Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription. |
| GO:0010226 | | response to lithium ion | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lithium (Li+) ion stimulus. |
| GO:0014070 | | response to organic cyclic compound | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus. |
| GO:0050909 | | sensory perception of taste | | The series of events required for an organism to receive a gustatory stimulus, convert it to a molecular signal, and recognize and characterize the signal. Gustation involves the direct detection of chemical composition, usually through contact with chemoreceptor cells. This is a neurological process. |
| GO:0043588 | | skin development | | The process whose specific outcome is the progression of the skin over time, from its formation to the mature structure. The skin is the external membranous integument of an animal. In vertebrates the skin generally consists of two layers, an outer nonsensitive and nonvascular epidermis (cuticle or skarfskin) composed of cells which are constantly growing and multiplying in the deeper, and being thrown off in the superficial layers, as well as an inner vascular dermis (cutis, corium or true skin) composed mostly of connective tissue. |
| GO:0001756 | | somitogenesis | | The formation of mesodermal clusters that are arranged segmentally along the anterior posterior axis of an embryo. |
| GO:0002040 | | sprouting angiogenesis | | The extension of new blood vessels from existing capillaries into avascular tissues resulting from the proliferation of blood vessel endothelial cells. |
| GO:0043401 | | steroid hormone mediated signaling pathway | | A series of molecular signals mediated by a steroid hormone binding to a receptor. |
| GO:0043586 | | tongue development | | The process whose specific outcome is the progression of the tongue over time, from its formation to the mature structure. The tongue is the movable, muscular organ on the floor of the mouth of most vertebrates, in many other mammals is the principal organ of taste, aids in the prehension of food, in swallowing, and in modifying the voice as in speech. |
| GO:0061153 | | trachea gland development | | The progression of a trachea gland over time, from its formation to the mature structure. Trachea glands are found under the mucus of the trachea and secrete mucus, and agents that help protect the lung from injury and infection. |
| GO:0006366 | | transcription from RNA polymerase II promoter | | The synthesis of RNA from a DNA template by RNA polymerase II, originating at an RNA polymerase II promoter. Includes transcription of messenger RNA (mRNA) and certain small nuclear RNAs (snRNAs). |
| GO:0006351 | | transcription, DNA-templated | | The cellular synthesis of RNA on a template of DNA. |
| GO:0001944 | | vasculature development | | The process whose specific outcome is the progression of the vasculature over time, from its formation to the mature structure. The vasculature is an interconnected tubular multi-tissue structure that contains fluid that is actively transported around the organism. |
cellular component |
| GO:1990907 | | beta-catenin-TCF complex | | A protein complex that contains beta-catenin and a member of the T-cell factor (TCF)/lymphoid enhancer binding factor (LEF) family of transcription factors. |
| GO:0005737 | | cytoplasm | | All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| GO:0005634 | | nucleus | | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
| GO:0032993 | | protein-DNA complex | | A macromolecular complex containing both protein and DNA molecules. |
| GO:0005667 | | transcription factor complex | | A protein complex that is capable of associating with DNA by direct binding, or via other DNA-binding proteins or complexes, and regulating transcription. |